John M Weiler
Physician in Iowa City, IA
License number
Colorado 35004
Issued Date
Jan 11, 1996
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
PO Box 69, Iowa City, IA 52244
Professional information
President, Compleware
Position:
President at CompleWare
Location:
Iowa City, Iowa Area
Industry:
Pharmaceuticals
Work:
CompleWare
since 1991
-
President
University of Iowa
1993 - 2002
-
Professor
Education:
Temple University
MD University of Iowa - Henry B. Tippie College of Business
MBA University of Michigan
BS
MD University of Iowa - Henry B. Tippie College of Business
MBA University of Michigan
BS
John Weiler, Iowa City IA
Work:
Iowa Clinical Research Corporation
205 E Burlington St, Iowa City, IA 52240
205 E Burlington St, Iowa City, IA 52240
Dr. John M Weiler, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Diagnostic Laboratory & Dermatologic Immunology
Address:
225E Burlington St W, Iowa City 52242
(319) 338-5552 (Phone)
(319) 338-5552 (Phone)
Certifications:
Allergy & Immunology, 2001, Diagnostic Laboratory Immunology, 1990, Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Temple University
Graduated: 1971
Indiana University
Graduated: 1972
Kans University Med Center
Graduated: 1975
Harvard U/Brigham Hospital
Graduated: 1977
Temple University
Graduated: 1971
Indiana University
Graduated: 1972
Kans University Med Center
Graduated: 1975
Harvard U/Brigham Hospital
Graduated: 1977
Low Molecular Weight Heparin Fragments As Inhibitors Of Complement Activation
US Patent:
4847338, Jul 11, 1989
Filed:
Jun 17, 1987
Appl. No.:
7/063170
Inventors:
Robert J. Linhardt - Iowa City IA
Zohar M. Merchant - Iowa City IA
John M. Weiler - Iowa City IA
Murali Sharath - Virginia Beach VA
Zohar M. Merchant - Iowa City IA
John M. Weiler - Iowa City IA
Murali Sharath - Virginia Beach VA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
C07H 1312, A61K 31725
US Classification:
536 54
Abstract:
There is disclosed a tetrasaccharide, a hexasaccharide, on octasaccharide and a decasaccharide all capable of inhibiting complement activation and having less tha 33% of undigested native heparin's anticoagulation activity.
Oligosaccharide Heparin Fragments As Inhibitors Of Complement Cascade
US Patent:
4916219, Apr 10, 1990
Filed:
Aug 2, 1988
Appl. No.:
7/227357
Inventors:
Robert J. Linhardt - Iowa City IA
John M. Weiler - Iowa City IA
John M. Weiler - Iowa City IA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A01N 4304, C08B 3710, C07G 3700, C07H 100
US Classification:
536 21
Abstract:
There is disclosed oligosaccharide compounds having heparin-like anticomplement activity and reduced anticoagulant activity as compared with heparin on a weight or molar basis. The oligosaccharide compounds have at least 5 and no greater than 25 saccharide units. The oligosaccharides can have an even nuber of saccharide units with a terminus nonreducing sugar, or an odd number of saccharide units without a terminus nonreducing sugar. There is also disclosed anticomplement pharmaceutical compositions with reduced anticoagulant side effect activity and a process for preparing the oligosaccharide compounds.